NGL Fine-Chem (NGLFINE) | Stock Overview & Key Data
NGL Fine-Chem Performance Comparison
Stock Range
Today's Range
Low: ₹1,437.20
High: ₹1,466.00
on October 3, 2025
52 Week Range
Low: ₹957.00
High: ₹2,178.90
on February 19, 2025
on October 15, 2024
All-Time High: ₹2,823.90 on April 22, 2024
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Market Cap
INR8.7B
EPS
34.30
P/E Ratio (TTM)
41.05
Forward P/E
N/A
P/B Ratio
3.08
PEG Ratio
153.11
Div. Yield
0.26%
ROE
7.48%
Beta
0.476
Debt to Equity
27.30
Financial Highlights
Profitability
Gross Margin
50.19%
Operating Margin
6.44%
Profit Margin
5.54%
Returns and Earnings
Return on Assets (TTM)
4.87%
Return on Equity (TTM)
7.48%
EBITDA
INR445.9M
Net Income (TTM)
INR211.5M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
INR617.82
Quarterly Revenue Growth (YoY)
14.80%
Quarterly Earnings Growth (YoY)
0.20%
Dividend Information
Last 12-Month Dividend
₹3.50
Current Dividend Yield
0.26%
3-Year Average Dividend Yield
0.10%
3-Year Average Annual Dividend
₹2.33
3-Year Total Dividends
₹7.00
Ex-Dividend Date
August 12, 2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| NGL Fine-Chem NGLFINE | 8.70B Small-cap | -0.36% | -2.44% | 24.30% | 27.33% | -20.23% | -25.88% | 0.54% | -23.08% |
| GlaxoSmithKline GLAXO | 458.57B Large-cap | -1.79% | -3.96% | -19.57% | -3.58% | 20.84% | -1.52% | 93.34% | 80.13% |
| Pfizer PFIZER | 231.58B Large-cap | 2.92% | 0.31% | -9.61% | 27.62% | -2.95% | -8.29% | 16.04% | 2.57% |
| Senores SENORES | 32.95B Small-cap | -4.06% | -1.93% | 18.10% | 22.01% | 20.44% | 20.06% | 20.06% | 20.06% |
| Sms Pharmaceuticals SMSPHARMA | 23.10B Small-cap | -7.69% | 9.34% | 3.92% | 17.65% | 0.50% | -29.15% | 185.52% | 181.63% |
| TTK Healthcare TTKHLTCARE | 16.28B Small-cap | -2.66% | 0.24% | -9.50% | -1.96% | -17.55% | -28.09% | 21.98% | 161.51% |
Ownership & Short Interest
Insider Ownership
73.79%
Institutional Ownership
0.00%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
3K
Average 90-Day Volume
3K
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is NGLFINE's 52-week high and low?
- In the last 52 weeks, NGL Fine-Chem reached a high of ₹2,178.90 (on October 15, 2024) and a low of ₹957.00 (on February 19, 2025).
- What is the market cap and P/E ratio for NGLFINE?
- Curious about NGL Fine-Chem's size and valuation? Its market capitalization stands at 8.70B. When it comes to valuation, the P/E ratio (trailing twelve months) is 41.05, and the forward P/E (looking ahead) is N/A.
- Does NGLFINE pay dividends? If so, what's the yield?
- Yes, NGL Fine-Chem is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 0.26%, and the company has paid an average of ₹2.33 per share annually over the past 3 years.
- Who are NGL Fine-Chem's main competitors or similar companies to consider before investing?
When looking at NGL Fine-Chem, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return GlaxoSmithKline
GLAXO458.57B Healthcare Drug Manufacturers - General -1.52% 93.34% Pfizer
PFIZER231.58B Healthcare Drug Manufacturers - General -8.29% 16.04% Senores
SENORES32.95B Healthcare Drug Manufacturers - General 20.06% 20.06% Sms Pharmaceuticals
SMSPHARMA23.10B Healthcare Drug Manufacturers - General -29.15% 185.52% TTK Healthcare
TTKHLTCARE16.28B Healthcare Drug Manufacturers - General -28.09% 21.98% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for NGL Fine-Chem Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of NGL Fine-Chem's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 7.48%, the Debt to Equity ratio from the most recent quarter is 27.30, and its Gross Profit Margin stands at 50.19%.
- What is the recent revenue and earnings growth for NGLFINE?
- Looking at NGL Fine-Chem's growth, its revenue over the trailing twelve months (TTM) was INR4B. Compared to the same quarter last year (YoY), quarterly revenue grew by 14.80%, and quarterly earnings saw a YoY growth of 0.20%.
- How much of NGLFINE stock is held by insiders and institutions?
- Wondering who owns NGL Fine-Chem stock? Company insiders (like executives and directors) hold about 73.79% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 0.00%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.